VA
BHC icon

Verdad Advisers’s Bausch Health BHC Stock Holding History

Verdad Advisers’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-45,000
Closed -$1.32M – 46
2021
Q2 		$1.32M Sell
45,000
-196,807
-81% -$5.96M 2.59% 19
2021
Q1 		$7.67M Hold
241,807
– – 2.45% 22
2020
Q4 		$5.03M Buy
+241,807
New +$4.51M 1.89% 28

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Verdad Advisers's BHC Position: Q3 2021 in Review

Verdad Advisers sold out of Bausch Health (BHC) in Q3 2021, closing a stake of 45,000 shares — an estimated $1.32M sold.

Verdad Advisers first reported a position in BHC in Q4 2020 and held it in 3 quarters. The position peaked at $7.67M in Q1 2021. 346 funds tracked by Wall St. Rank hold BHC as of Q3 2021.

  • Verdad Advisers reported no remaining Bausch Health position as of Q3 2021 after selling out during the quarter.
  • Verdad Advisers sold 45,000 Bausch Health shares in Q3 2021, an estimated $1.32M.
  • Verdad Advisers first reported a position in Bausch Health in Q4 2020 and held it in 3 quarters.
  • Verdad Advisers's Bausch Health position peaked at $7.67M in Q1 2021.
  • 346 funds tracked by Wall St. Rank held Bausch Health as of Q3 2021.

Based on Verdad Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.